134 related articles for article (PubMed ID: 13336382)
41. Automated histometry in fibrocystic breast disease.
Guski H; Hufnagl P; Freitag A; Wenzelides K; Voss K; Simon H
Anal Quant Cytol Histol; 1988 Apr; 10(2):101-6. PubMed ID: 3390284
[TBL] [Abstract][Full Text] [Related]
42. [Fibrocystic disease of breast and pituitary-thyroid axis function].
Zych F; Mizia-Stec K; Mucha Z; Zych-Twardowska E
Pol Merkur Lekarski; 1996 Oct; 1(4):227-8. PubMed ID: 9156929
[TBL] [Abstract][Full Text] [Related]
43. [Notes on the agalactogenic action of the pituitary inhibitor p-hydroxypropiophenone].
MASSANO A
Minerva Ginecol; 1957 Dec; 9(23):990-2. PubMed ID: 13516693
[No Abstract] [Full Text] [Related]
44. [Fibrocystic mastopathy. (Current concepts of pathogenesis and therapy)].
D'INCERTI BONINI L
Ann Ostet Ginecol; 1960 Feb; 82():107-36. PubMed ID: 13813622
[No Abstract] [Full Text] [Related]
45. [Clinical observations on the action of p-hydroxypropiophenone in 4 cases of malignant tumors].
CUCINOTTA U
Oncologia; 1954; 7(3):223-31. PubMed ID: 13185591
[No Abstract] [Full Text] [Related]
46. [Fibrocystic mastopathy in supernumerary axillary breast with no nipple].
FERRANTI L; CAVALLINI A
Arcisp S Anna Ferrara; 1954; 7(3):401-3. PubMed ID: 13218980
[No Abstract] [Full Text] [Related]
47. [Endocrine characteristics of women with fibrocystic mastopathy].
Melis GB; Guarnieri G; Paoletti AM; Cappelli N; Selli M; Petacchi FD; Ruju A; Fioretti P
Minerva Ginecol; 1982 Nov; 34(11):897-901. PubMed ID: 7155415
[No Abstract] [Full Text] [Related]
48. [Possibility of use of p-hydroxypropiophenone in insulin therapy of mental disorders].
FEDELI S; GHISONI T
Policlinico Med; 1954; 61(5):373-84. PubMed ID: 13215126
[No Abstract] [Full Text] [Related]
49. [Para-hydroxypropiophenone in therapy of climacteric complications].
MELKILD A
Nord Med; 1957 Jun; 57(26):926-7. PubMed ID: 13452164
[No Abstract] [Full Text] [Related]
50. [Comparison of the diagnostic value of the individual examination steps (triple diagnosis) in breast cysts].
Fitzal P; Wolf G
Ultraschall Med; 1990 Aug; 11(4):202-5. PubMed ID: 2259915
[TBL] [Abstract][Full Text] [Related]
51. [CONTRIBUTION TO ELECTRON MICROSCOPIC CELL DIFFERENTIATION OF THE SOLID MAMMARY CARCINOMA AND CYSTIC MASTOPATHY IN HUMANS].
BERGER H
Z Krebsforsch; 1964 Feb; 66():73-86. PubMed ID: 14154139
[No Abstract] [Full Text] [Related]
52. [Therapy of simple goiter with reference to 34 cases treated with thyroxin & p-hydroxypropiophenone].
MINOZZI M; FAGGIANO M; ROSSANO P
Clin Ter; 1958 Sep; 15(3):222-42. PubMed ID: 13597125
[No Abstract] [Full Text] [Related]
53. [Our clinico-therapeutic attitude to fibrocystic mastopathy].
Fabi P; Zamboni P; Mari C; Tartari V; Nigro Imperiale F; Gasbarro V; Bignami R; Rubbini M; Pozza E; De Anna D
Chir Ital; 1984 Feb; 36(1):26-9. PubMed ID: 6525671
[TBL] [Abstract][Full Text] [Related]
54. [Use of hypophyseal blocking agents in the treatment of malignant tumors, especially those of the breast].
GRAPULIN G
Chir Ital; 1957 Feb; 9(1):60-87. PubMed ID: 13437383
[No Abstract] [Full Text] [Related]
55. [Use of pituitary inhibitors in the treatment of malignant tumors, particularly breast tumors].
GRAPULIN G
Therapie; 1957; 12(4):583-600. PubMed ID: 13467835
[No Abstract] [Full Text] [Related]
56. [2 Cases of nevo-carcinoma with recurrent lymph node involvement treated by autograft & p-hydroxypropiophenone; continued remission after 6 years].
BOLGERT M; LE SOURD M
Bull Soc Fr Dermatol Syphiligr; 1958; 65(1):52-3. PubMed ID: 13546909
[No Abstract] [Full Text] [Related]
57. [Results of the use of vitamins A and E in a sample of 256 women with fibrocystic mastopathy].
Brignone G; Gugliuzza M; Pindaro L
Minerva Ginecol; 1988 Jan; 40(1):29-31. PubMed ID: 3374831
[No Abstract] [Full Text] [Related]
58. [Anti-gonadotropic action of possipione].
GUSTAVO RP
Quad Clin Ostet Ginecol; 1958 Jul; 13(7):307-15. PubMed ID: 13579130
[No Abstract] [Full Text] [Related]
59. [Current concepts of fibrocystic mastopathy].
Samoĭlova TE
Akush Ginekol (Mosk); 1986 Feb; (2):3-6. PubMed ID: 3010757
[No Abstract] [Full Text] [Related]
60. [Interaction between beta-endorphin, steroids and peptide hormones in fibrocystic lesions of the female breast].
Schurz B
Wien Klin Wochenschr Suppl; 1991; 187():3-26. PubMed ID: 1648846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
